Navigation Links
Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
Date:11/4/2009

iability.

Use of Non-GAAP Measures

To supplement our consolidated financial statements presented in accordance with GAAP, we use the following measures defined as non-GAAP financial measures by the SEC: non-GAAP net loss and non-GAAP loss per basic and diluted share. The presentation of this financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. In addition, the non-GAAP financial measures included in this press release may be different from, and therefore not comparable to, similar measures used by other companies. Although certain non-GAAP financial measures used in this release exclude the accounting treatment of valuation adjustments associated with our outstanding warrants to purchase shares of our common stock, these non-GAAP measures should not be relied upon independently.

Our management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our performance by excluding certain expenses and expenditures that may not be indicative of our core business operating results. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate management's internal comparisons to our historical performance and our competitors' operating results. We believe that these non-GAAP measures are useful to investors in allowing for greater transparency with respect to supplemental information used by management in its financial and operational decision making.

CONFERENCE CALL INFORMATION

Savient's management team will host a live conference call and Webcast on Thursday, November 5 at 10:00 a.m. Eastern Time/7:00 a.m. Pacific Time to review the third quarter financial re
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 Hemoglobin A1C levels ... with Type 2 diabetes, while modest improvements in ... outcomes and can lead to substantial healthcare cost ... International Society for Pharmacoeconomics and Outcomes Research (ISPOR) ... studies, sponsored by Valeritas, makers of the V-Go ...
(Date:5/22/2013)... 2013 Ranbaxy Laboratories Limited (hereafter, Ranbaxy), ... Daiichi Sankyo), announced on May 22 the actions ... address past conduct under prior management ... Sankyo continues to support Ranbaxy in its efforts ... past which led to the investigations by the ...
(Date:5/22/2013)...  Ohr Pharmaceutical Inc. (OTCQB: OHRP), a pharmaceutical company ... medical needs, today announced the appointment of ... Board of Directors. Dr. Almenoff has extensive experience in ... drug development. "We are delighted to ... Taraporewala, CEO of Ohr Pharmaceutical. "She offers tremendous expertise ...
Breaking Medicine Technology:Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 2Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 3
... LOUIS, May 2, 2012  Stereotaxis, Inc. (NASDAQ: ... release financial results for the first quarter 2012 ... of the U.S. financial markets.  The Company will ... a.m. Eastern Time that day to discuss the ...
... OMER ), a biopharmaceutical company committed to ... and disorders of the central nervous system, today announced ... officer, is scheduled to present at the Deutsche Bank ... presentation is scheduled for 10:00 a.m. Eastern Time on ...
Cached Medicine Technology:Stereotaxis to Report First Quarter 2012 Financial Results on May 8, 2012 2Stereotaxis to Report First Quarter 2012 Financial Results on May 8, 2012 3
(Date:5/22/2013)... (PRWEB) May 22, 2013 Today, Zane ... Alabama Health Insurance Exchange . Zane Benefits, which provides ... benefits, is the leader in defined contribution plans ... to Zane Benefits’ website, beginning in 2014 as part ... for individuals and small businesses will become available through ...
(Date:5/22/2013)... FRANCISCO Researchers in genomic health disparities from the ... Stanford University School of Medicine have teamed up to ... to Eliminate Health Disparities in Genomic Medicine." The ... of nonprofits, business and government to reduce these disparities. ... the United States, individuals within underserved groups continue to ...
(Date:5/22/2013)... Reporter , , WEDNESDAY, May 22 (HealthDay News) -- Migraines ... suffering, but new research indicates the combination of the ... a smaller brain. , , Already aware that people ... wanted to determine if having both conditions together affected ... 2 percent -- isn,t alarming, study authors said, but ...
(Date:5/22/2013)... York, US (PRWEB) May 22, 2013 ... Awards , Read the press release here: http://bit.ly/13DkFfk ... Merrill DataSite® was named “Information Management Product/Service of the ... held in March at The Colony Hotel in Palm ... secure virtual data room (VDR) solution that ...
(Date:5/22/2013)... 2013 Recent tragedies including the ... school shooting in Newtown, Connecticut all resulted in ... , Emergency medical practitioners train to respond to ... Medical Services for Children (EMSC) Program specifically provides ... the youngest patients. It is estimated 30 million ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 3Health News:Why We Can't Wait: Conference to Eliminate Health Disparities in Genomic Medicine 2Health News:Having Both Migraines, Depression May Mean Smaller Brain 2Health News:Having Both Migraines, Depression May Mean Smaller Brain 3Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 2Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 3Health News:When Tragedies Impact Children – Kentucky Emergency Medical Services for Children (KYEMSC) Offers Specialized Training for Pediatric Emergency Care 2
... Ill., Nov. 12 Pregis Corporation, a leading international ... specialty packaging solutions, today announced its 2009 third quarter ... of 2009, the Company generated net sales of $207.0 ... $265.2 million in the third quarter of 2008. Excluding ...
... protein involved in blood-brain barrier , THURSDAY, Nov. 12 ... on the brain, but it,s too early to say ... researcher reports. , Fredrik Soderqvist, of Orebro University, analyzed ... they had elevated levels of a protein called transthyretin, ...
... eating dark version lowered levels of stress hormones , THURSDAY, ... dark chocolate could cheer you right up by lowering your ... who report their findings in the online issue of the ... said they were highly stressed. , "The study provides strong ...
... ... P.C. has opened its new facility in Lake Success, NY. The facility will ... Epilepsy Neurologist Alan B. Ettinger, M.D., Neuro-Ophthalmologist Scott Uretsky, M.D., Neuropsychologist Gad E. ... children’s facility designed for the needs of pediatric patients. , ...
... Healthcare is an industry faced with unprecedented uncertainty. ... overcome the noise and clearly communicate relevant and timely ... company Griffin York & Krause (GY&K) reaffirmed its commitment ... been honored with six national CardioVascular Advertising (CVA) Awards. ...
... BEACH, Fla., Nov. 12 Commerce Online Inc. (Pink ... company specializing in both bricks and mortar and online ... partnership with RedFin Network, Inc. ( www.redfinnet.com ... Inc. (OTC Bulletin Board: SFNL), to launch its ...
Cached Medicine News:Health News:Pregis Announces Third Quarter 2009 Financial Results 2Health News:Pregis Announces Third Quarter 2009 Financial Results 3Health News:Pregis Announces Third Quarter 2009 Financial Results 4Health News:Pregis Announces Third Quarter 2009 Financial Results 5Health News:Pregis Announces Third Quarter 2009 Financial Results 6Health News:Pregis Announces Third Quarter 2009 Financial Results 7Health News:Pregis Announces Third Quarter 2009 Financial Results 8Health News:Pregis Announces Third Quarter 2009 Financial Results 9Health News:Pregis Announces Third Quarter 2009 Financial Results 10Health News:Pregis Announces Third Quarter 2009 Financial Results 11Health News:Pregis Announces Third Quarter 2009 Financial Results 12Health News:Pregis Announces Third Quarter 2009 Financial Results 13Health News:Pregis Announces Third Quarter 2009 Financial Results 14Health News:Pregis Announces Third Quarter 2009 Financial Results 15Health News:Pregis Announces Third Quarter 2009 Financial Results 16Health News:Wireless Phones Alter Levels of Brain Chemical 2Health News:Neurological Surgery, P.C., of Long Island, NY, Adds New Specialists and Opens New Flagship Facility in Lake Success, NY 2Health News:Neurological Surgery, P.C., of Long Island, NY, Adds New Specialists and Opens New Flagship Facility in Lake Success, NY 3Health News:Healthcare Organizations Face Tough Marketing Challenges - GY&K Asks 'Are You Relevant?' 2Health News:Healthcare Organizations Face Tough Marketing Challenges - GY&K Asks 'Are You Relevant?' 3Health News:Commerce Online Announces Agreement With RedFin Network For Medical Marijuana Dispensary Pre-Paid Loyalty Card Program 2Health News:Commerce Online Announces Agreement With RedFin Network For Medical Marijuana Dispensary Pre-Paid Loyalty Card Program 3
... is a service that directly connects ... the customers laboratory to the Thermo ... U.S.A., and Runcorn, U.K.* By using ... customer site, high-value support services are ...
... Grossing Wokrstation is a durable, safety-driven, ... gross examination and sectioning of specimens. ... efficient ventilation systems and options of ... faucets, table rinses, disposals and dictation ...
... The Shandon Gross-Star Grossing Workbench ... workbench designed for gross examination and ... steel construction, downdraft ventilation with a ... foot pedal controls for cold/hot water ...
... HypercleanTM 22 fume containment system ... a one- or two-person work ... containment system comes complete ... four charcoal filters. (For replacement ...
Medicine Products: